2024-03-04
|
R-HSA-9660821
|
ADORA2B mediated anti-inflammatory cytokines production
|
BibTex
|
2024-03-04
|
R-HSA-9634597
|
GPER1 signaling
|
BibTex
|
2024-03-04
|
R-HSA-1430728
|
Metabolism
|
BibTex
|
2024-03-04
|
R-HSA-420092
|
Glucagon-type ligand receptors
|
BibTex
|
2024-03-04
|
R-HSA-163615
|
PKA activation
|
BibTex
|
2024-03-01
|
R-HSA-432040
|
Vasopressin regulates renal water homeostasis via Aquaporins
|
BibTex
|
2024-02-19
|
R-HSA-428643
|
Organic anion transporters
|
BibTex
|
2024-02-19
|
R-HSA-389661
|
Glyoxylate metabolism and glycine degradation
|
BibTex
|
2024-02-08
|
R-HSA-389542
|
NADPH regeneration
|
BibTex
|
2024-01-29
|
R-HSA-9634597
|
GPER1 signaling
|
BibTex
|
2024-01-29
|
R-HSA-163615
|
PKA activation
|
BibTex
|
2024-01-29
|
R-HSA-420092
|
Glucagon-type ligand receptors
|
BibTex
|
2024-01-29
|
R-HSA-9660821
|
ADORA2B mediated anti-inflammatory cytokines production
|
BibTex
|
2023-12-08
|
R-HSA-5663202
|
Diseases of signal transduction by growth factor receptors and second messengers
|
BibTex
|
2023-10-27
|
R-HSA-1660662
|
Glycosphingolipid metabolism
|
BibTex
|
2023-10-26
|
R-HSA-382551
|
Transport of small molecules
|
BibTex
|
2023-10-24
|
R-HSA-428157
|
Sphingolipid metabolism
|
BibTex
|
2023-10-24
|
R-HSA-9845576
|
Glycosphingolipid transport
|
BibTex
|
2023-10-24
|
R-HSA-1660662
|
Glycosphingolipid metabolism
|
BibTex
|
2023-10-24
|
R-HSA-9840309
|
Glycosphingolipid biosynthesis
|
BibTex
|
2023-10-24
|
R-HSA-9845614
|
Sphingolipid catabolism
|
BibTex
|
2023-10-24
|
R-HSA-1660661
|
Sphingolipid de novo biosynthesis
|
BibTex
|
2023-10-13
|
R-HSA-9006934
|
Signaling by Receptor Tyrosine Kinases
|
BibTex
|
2023-08-22
|
R-HSA-196071
|
Metabolism of steroid hormones
|
BibTex
|
2023-08-22
|
R-HSA-71387
|
Metabolism of carbohydrates
|
BibTex
|
2023-08-22
|
R-HSA-9840310
|
Glycosphingolipid catabolism
|
BibTex
|
2023-08-17
|
R-HSA-1660661
|
Sphingolipid de novo biosynthesis
|
BibTex
|
2023-08-17
|
R-HSA-428157
|
Sphingolipid metabolism
|
BibTex
|
2023-08-17
|
R-HSA-1660662
|
Glycosphingolipid metabolism
|
BibTex
|
2023-08-17
|
R-HSA-9840309
|
Glycosphingolipid biosynthesis
|
BibTex
|
2023-01-27
|
R-HSA-9824443
|
Parasitic Infection Pathways
|
BibTex
|
2023-01-27
|
R-HSA-9824446
|
Viral Infection Pathways
|
BibTex
|
2023-01-27
|
R-HSA-9824439
|
Bacterial Infection Pathways
|
BibTex
|
2022-01-05
|
R-HSA-9758274
|
Regulation of NF-kappa B signaling
|
BibTex
|
2021-12-13
|
R-HSA-9759785
|
Diseases of propionyl-CoA catabolism
|
BibTex
|
2021-09-23
|
R-HSA-9748784
|
Drug ADME
|
BibTex
|
2021-08-18
|
R-HSA-9734009
|
Defective Intrinsic Pathway for Apoptosis
|
BibTex
|
2021-02-25
|
R-HSA-9716542
|
Signaling by Rho GTPases, Miro GTPases and RHOBTB3
|
BibTex
|
2021-02-17
|
R-HSA-9710421
|
Defective pyroptosis
|
BibTex
|
2021-02-17
|
R-HSA-5620971
|
Pyroptosis
|
BibTex
|
2021-01-27
|
R-HSA-9692916
|
SARS-CoV-1 activates/modulates innate immune responses
|
BibTex
|
2021-01-26
|
R-HSA-9709957
|
Sensory Perception
|
BibTex
|
2021-01-26
|
R-HSA-9692914
|
SARS-CoV-1-host interactions
|
BibTex
|
2021-01-26
|
R-HSA-9735871
|
SARS-CoV-1 targets host intracellular signalling and regulatory pathways
|
BibTex
|
2021-01-26
|
R-HSA-9735869
|
SARS-CoV-1 modulates host translation machinery
|
BibTex
|
2021-01-26
|
R-HSA-9692912
|
SARS-CoV-1 targets PDZ proteins in cell-cell junction
|
BibTex
|
2021-01-26
|
R-HSA-9692913
|
SARS-CoV-1-mediated effects on programmed cell death
|
BibTex
|
2020-11-11
|
R-HSA-9675135
|
Diseases of DNA repair
|
BibTex
|
2020-11-11
|
R-HSA-9675136
|
Diseases of DNA Double-Strand Break Repair
|
BibTex
|
2020-08-18
|
R-HSA-9675151
|
Disorders of Developmental Biology
|
BibTex
|
2020-08-14
|
R-HSA-9697154
|
Disorders of Nervous System Development
|
BibTex
|
2020-06-26
|
R-HSA-9693928
|
Defective RIPK1-mediated regulated necrosis
|
BibTex
|
2020-06-26
|
R-HSA-9686347
|
Microbial modulation of RIPK1-mediated regulated necrosis
|
BibTex
|
2020-02-24
|
R-HSA-9675132
|
Diseases of cellular response to stress
|
BibTex
|
2020-02-24
|
R-HSA-9675151
|
Disorders of Developmental Biology
|
BibTex
|
2020-02-24
|
R-HSA-9675135
|
Diseases of DNA repair
|
BibTex
|
2020-02-24
|
R-HSA-9675143
|
Diseases of the neuronal system
|
BibTex
|
2020-01-09
|
R-HSA-9671793
|
Diseases of hemostasis
|
BibTex
|
2020-01-09
|
R-HSA-9651496
|
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)
|
BibTex
|
2020-01-09
|
R-HSA-9672383
|
Defective factor IX causes thrombophilia
|
BibTex
|
2020-01-09
|
R-HSA-9672387
|
Defective F8 accelerates dissociation of the A2 domain
|
BibTex
|
2020-01-09
|
R-HSA-9674519
|
Defective F8 sulfation at Y1699
|
BibTex
|
2020-01-09
|
R-HSA-9672391
|
Defective F8 cleavage by thrombin
|
BibTex
|
2020-01-09
|
R-HSA-9672395
|
Defective F8 binding to the cell membrane
|
BibTex
|
2020-01-09
|
R-HSA-9672393
|
Defective F8 binding to von Willebrand factor
|
BibTex
|
2020-01-09
|
R-HSA-9672397
|
Defective F8 secretion
|
BibTex
|
2020-01-09
|
R-HSA-9672396
|
Defective cofactor function of FVIIIa variant
|
BibTex
|
2020-01-09
|
R-HSA-9662001
|
Defective factor VIII causes hemophilia A
|
BibTex
|
2020-01-09
|
R-HSA-9673218
|
Defective F9 secretion
|
BibTex
|
2020-01-09
|
R-HSA-9673202
|
Defective F9 variant does not activate FX
|
BibTex
|
2020-01-09
|
R-HSA-9673221
|
Defective F9 activation
|
BibTex
|
2020-01-09
|
R-HSA-9673240
|
Defective gamma-carboxylation of F9
|
BibTex
|
2020-01-09
|
R-HSA-9668250
|
Defective factor IX causes hemophilia B
|
BibTex
|
2020-01-09
|
R-HSA-9657689
|
Defective SERPING1 causes hereditary angioedema
|
BibTex
|
2020-01-09
|
R-HSA-9657688
|
Defective factor XII causes hereditary angioedema
|
BibTex
|
2018-12-29
|
R-HSA-9024446
|
NR1H2 and NR1H3-mediated signaling
|
BibTex
|
2018-12-29
|
R-HSA-9029558
|
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
|
BibTex
|
2018-12-29
|
R-HSA-9632974
|
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis
|
BibTex
|
2018-12-29
|
R-HSA-9031525
|
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake
|
BibTex
|
2018-12-29
|
R-HSA-9623433
|
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
|
BibTex
|
2018-12-29
|
R-HSA-9031528
|
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose
|
BibTex
|
2018-12-29
|
R-HSA-9029569
|
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
|
BibTex
|
2018-12-22
|
R-HSA-434313
|
Intracellular metabolism of fatty acids regulates insulin secretion
|
BibTex
|
2017-12-02
|
R-HSA-8983711
|
OAS antiviral response
|
BibTex
|
2017-06-22
|
R-HSA-9006934
|
Signaling by Receptor Tyrosine Kinases
|
BibTex
|
2017-06-22
|
R-HSA-9006931
|
Signaling by Nuclear Receptors
|
BibTex
|
2017-06-22
|
R-HSA-9006936
|
Signaling by TGFB family members
|
BibTex
|
2017-06-22
|
R-HSA-9006927
|
Signaling by Non-Receptor Tyrosine Kinases
|
BibTex
|
2017-06-22
|
R-HSA-9006925
|
Intracellular signaling by second messengers
|
BibTex
|
2017-02-10
|
R-HSA-8963743
|
Digestion and absorption
|
BibTex
|
2016-10-11
|
R-HSA-8937144
|
Aryl hydrocarbon receptor signalling
|
BibTex
|
2016-10-11
|
R-HSA-8942233
|
Intestinal infectious diseases
|
BibTex
|
2016-08-18
|
R-HSA-8863678
|
Neurodegenerative Diseases
|
BibTex
|
2016-08-12
|
R-HSA-8935690
|
Digestion
|
BibTex
|
2016-07-15
|
R-HSA-8877627
|
Vitamin E
|
BibTex
|
2016-04-20
|
R-HSA-8963889
|
Assembly of active LPL and LIPC lipase complexes
|
BibTex
|
2016-04-05
|
R-HSA-8964572
|
Lipid particle organization
|
BibTex
|
2016-04-05
|
R-HSA-8866376
|
Reelin signalling pathway
|
BibTex
|
2016-04-05
|
R-HSA-8866427
|
VLDLR internalisation and degradation
|
BibTex
|
2016-04-05
|
R-HSA-8964046
|
VLDL clearance
|
BibTex
|
2016-04-05
|
R-HSA-8866423
|
VLDL assembly
|
BibTex
|
2016-01-26
|
R-HSA-8853383
|
Lysosomal oligosaccharide catabolism
|
BibTex
|
2016-01-11
|
R-HSA-8852405
|
Signaling by MST1
|
BibTex
|
2016-01-11
|
R-HSA-8849175
|
Threonine catabolism
|
BibTex
|
2016-01-11
|
R-HSA-6798163
|
Choline catabolism
|
BibTex
|
2015-09-14
|
R-HSA-6787639
|
GDP-fucose biosynthesis
|
BibTex
|
2015-09-12
|
R-HSA-5686938
|
Regulation of TLR by endogenous ligand
|
BibTex
|
2015-08-17
|
R-HSA-5687613
|
Diseases associated with surfactant metabolism
|
BibTex
|
2015-08-17
|
R-HSA-5688890
|
Defective CSF2RA causes SMDP4
|
BibTex
|
2015-08-17
|
R-HSA-5687868
|
Defective SFTPA2 causes IPF
|
BibTex
|
2015-08-17
|
R-HSA-5688399
|
Defective ABCA3 causes SMDP3
|
BibTex
|
2015-08-17
|
R-HSA-5688031
|
Defective pro-SFTPB causes SMDP1 and RDS
|
BibTex
|
2015-08-17
|
R-HSA-5687583
|
Defective SLC34A2 causes PALM
|
BibTex
|
2015-08-17
|
R-HSA-5688849
|
Defective CSF2RB causes SMDP5
|
BibTex
|
2015-08-17
|
R-HSA-5688354
|
Defective pro-SFTPC causes SMDP2 and RDS
|
BibTex
|
2015-08-17
|
R-HSA-5683826
|
Surfactant metabolism
|
BibTex
|
2015-06-26
|
R-HSA-6783984
|
Glycine degradation
|
BibTex
|
2015-02-22
|
R-HSA-75876
|
Synthesis of very long-chain fatty acyl-CoAs
|
BibTex
|
2015-02-11
|
R-HSA-5223345
|
Miscellaneous transport and binding events
|
BibTex
|
2015-02-11
|
R-HSA-8981607
|
Intracellular oxygen transport
|
BibTex
|
2014-09-06
|
R-HSA-5260271
|
Diseases of Immune System
|
BibTex
|
2014-09-06
|
R-HSA-5602358
|
Diseases associated with the TLR signaling cascade
|
BibTex
|
2014-09-06
|
R-HSA-5602410
|
TLR3 deficiency - HSE
|
BibTex
|
2014-09-06
|
R-HSA-5602571
|
TRAF3 deficiency - HSE
|
BibTex
|
2014-09-06
|
R-HSA-5602680
|
MyD88 deficiency (TLR5)
|
BibTex
|
2014-09-06
|
R-HSA-5602415
|
UNC93B1 deficiency - HSE
|
BibTex
|
2014-09-06
|
R-HSA-5602636
|
IKBKB deficiency causes SCID
|
BibTex
|
2014-09-06
|
R-HSA-5603037
|
IRAK4 deficiency (TLR5)
|
BibTex
|
2014-09-06
|
R-HSA-5602498
|
MyD88 deficiency (TLR2/4)
|
BibTex
|
2014-09-06
|
R-HSA-5603027
|
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
|
BibTex
|
2014-09-06
|
R-HSA-5603041
|
IRAK4 deficiency (TLR2/4)
|
BibTex
|
2014-09-06
|
R-HSA-5602566
|
TICAM1 deficiency - HSE
|
BibTex
|
2014-09-06
|
R-HSA-5603029
|
IkBA variant leads to EDA-ID
|
BibTex
|
2014-05-22
|
R-HSA-5423646
|
Aflatoxin activation and detoxification
|
BibTex
|
2014-02-07
|
R-HSA-5173105
|
O-linked glycosylation
|
BibTex
|
2014-02-07
|
R-HSA-5173214
|
O-glycosylation of TSR domain-containing proteins
|
BibTex
|
2013-04-15
|
R-HSA-196741
|
Cobalamin (Cbl, vitamin B12) transport and metabolism
|
BibTex
|
2013-02-11
|
R-HSA-3134963
|
DEx/H-box helicases activate type I IFN and inflammatory cytokines production
|
BibTex
|
2013-02-11
|
R-HSA-3249367
|
STAT6-mediated induction of chemokines
|
BibTex
|
2013-02-11
|
R-HSA-3270619
|
IRF3-mediated induction of type I IFN
|
BibTex
|
2013-02-11
|
R-HSA-3134973
|
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
|
BibTex
|
2013-02-11
|
R-HSA-3134975
|
Regulation of innate immune responses to cytosolic DNA
|
BibTex
|
2013-02-11
|
R-HSA-3248023
|
Regulation by TREX1
|
BibTex
|
2012-11-07
|
R-GGA-2132285
|
Complement Cascade
|
BibTex
|
2012-11-07
|
R-GGA-2132287
|
Creation of alternative pathway C3 convertase
|
BibTex
|
2012-11-07
|
R-GGA-2132293
|
Formation of fluid-phase convertase C3
|
BibTex
|
2012-11-07
|
R-GGA-2173345
|
Anaphylatoxins initiate inflammatory responses
|
BibTex
|
2012-11-07
|
R-GGA-2132270
|
Lectin-mediated initiation of complement cascade
|
BibTex
|
2012-11-07
|
R-GGA-2132286
|
Classical antibody-mediated complement activation
|
BibTex
|
2012-11-07
|
R-GGA-2132263
|
Creation of classical C3 convertase
|
BibTex
|
2012-11-07
|
R-GGA-2132281
|
Regulation of complement cascades
|
BibTex
|
2012-11-07
|
R-GGA-2132267
|
Formation of membrane attack complex (MAC)
|
BibTex
|
2012-11-07
|
R-GGA-2132273
|
Formation of membrane-bound convertase C3
|
BibTex
|
2012-11-05
|
R-GGA-2422406
|
Innate Immune System
|
BibTex
|
2012-07-18
|
R-HSA-1834941
|
STING mediated induction of host immune responses
|
BibTex
|
2012-05-20
|
R-HSA-8953897
|
Cellular responses to stimuli
|
BibTex
|
2012-05-20
|
R-HSA-2262752
|
Cellular responses to stress
|
BibTex
|
2012-05-20
|
R-HSA-1483257
|
Phospholipid metabolism
|
BibTex
|
2012-05-14
|
R-HSA-1663150
|
The activation of arylsulfatases
|
BibTex
|
2012-04-23
|
R-HSA-881907
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
BibTex
|
2012-04-23
|
R-HSA-2179392
|
EGFR Transactivation by Gastrin
|
BibTex
|
2012-03-28
|
R-HSA-1630316
|
Glycosaminoglycan metabolism
|
BibTex
|
2012-03-28
|
R-HSA-2142845
|
Hyaluronan metabolism
|
BibTex
|
2012-03-28
|
R-HSA-2160916
|
Hyaluronan uptake and degradation
|
BibTex
|
2012-03-28
|
R-HSA-2142850
|
Hyaluronan biosynthesis and export
|
BibTex
|
2012-03-28
|
R-HSA-1793185
|
Chondroitin sulfate/dermatan sulfate metabolism
|
BibTex
|
2012-03-28
|
R-HSA-2024101
|
CS/DS degradation
|
BibTex
|
2012-03-28
|
R-HSA-2022870
|
Chondroitin sulfate biosynthesis
|
BibTex
|
2012-03-28
|
R-HSA-2022923
|
Dermatan sulfate biosynthesis
|
BibTex
|
2012-03-28
|
R-HSA-1638091
|
Heparan sulfate/heparin (HS-GAG) metabolism
|
BibTex
|
2012-03-28
|
R-HSA-2024096
|
HS-GAG degradation
|
BibTex
|
2012-03-28
|
R-HSA-2022857
|
Keratan sulfate degradation
|
BibTex
|
2012-03-28
|
R-HSA-2022854
|
Keratan sulfate biosynthesis
|
BibTex
|
2012-03-28
|
R-HSA-1638074
|
Keratan sulfate/keratin metabolism
|
BibTex
|
2012-03-28
|
R-HSA-1971475
|
A tetrasaccharide linker sequence is required for GAG synthesis
|
BibTex
|
2012-03-28
|
R-HSA-2022928
|
HS-GAG biosynthesis
|
BibTex
|
2012-02-28
|
R-HSA-1474244
|
Extracellular matrix organization
|
BibTex
|
2012-02-28
|
R-HSA-1474228
|
Degradation of the extracellular matrix
|
BibTex
|
2011-12-08
|
R-HSA-1834949
|
Cytosolic sensors of pathogen-associated DNA
|
BibTex
|
2011-12-08
|
R-HSA-1606322
|
ZBP1(DAI) mediated induction of type I IFNs
|
BibTex
|
2011-12-08
|
R-HSA-1810476
|
RIP-mediated NFkB activation via ZBP1
|
BibTex
|
2011-12-08
|
R-HSA-1606341
|
IRF3 mediated activation of type 1 IFN
|
BibTex
|
2011-11-02
|
R-HSA-1268020
|
Mitochondrial protein import
|
BibTex
|
2011-10-26
|
R-HSA-977347
|
Serine biosynthesis
|
BibTex
|
2011-10-13
|
R-HSA-1614635
|
Sulfur amino acid metabolism
|
BibTex
|
2011-10-13
|
R-HSA-1614558
|
Degradation of cysteine and homocysteine
|
BibTex
|
2011-10-13
|
R-HSA-1614517
|
Sulfide oxidation to sulfate
|
BibTex
|
2011-10-13
|
R-HSA-1614603
|
Cysteine formation from homocysteine
|
BibTex
|
2011-08-23
|
R-HSA-1474151
|
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
|
BibTex
|
2011-08-23
|
R-HSA-382556
|
ABC-family proteins mediated transport
|
BibTex
|
2011-08-23
|
R-HSA-1369007
|
Mitochondrial ABC transporters
|
BibTex
|
2011-08-23
|
R-HSA-1369062
|
ABC transporters in lipid homeostasis
|
BibTex
|
2011-05-23
|
R-HSA-156590
|
Glutathione conjugation
|
BibTex
|
2011-05-23
|
R-HSA-174403
|
Glutathione synthesis and recycling
|
BibTex
|
2011-05-23
|
R-HSA-1237112
|
Methionine salvage pathway
|
BibTex
|
2010-12-06
|
R-GGA-451529
|
TLR15 cascade
|
BibTex
|
2010-12-06
|
R-GGA-451531
|
TLR21 cascade
|
BibTex
|
2010-12-06
|
R-GGA-451498
|
TLR7 cascade
|
BibTex
|
2010-12-06
|
R-GGA-451477
|
MyD88-dependent cascade initiated on endosome membrane
|
BibTex
|
2010-12-06
|
R-GGA-573298
|
NFkB and MAPK activation mediated by TRAF6 upon TLR7 or TLR21 stimulation
|
BibTex
|
2010-12-06
|
R-GGA-451534
|
TLR5 cascade
|
BibTex
|
2010-12-06
|
R-GGA-977240
|
MyD88 cascade initiated on plasma membrane
|
BibTex
|
2010-11-09
|
R-HSA-975634
|
Retinoid metabolism and transport
|
BibTex
|
2010-11-08
|
R-HSA-964975
|
Vitamin B6 activation to pyridoxal phosphate
|
BibTex
|
2010-11-05
|
R-HSA-947581
|
Molybdenum cofactor biosynthesis
|
BibTex
|
2010-11-05
|
R-HSA-917937
|
Iron uptake and transport
|
BibTex
|
2010-11-05
|
R-HSA-917977
|
Transferrin endocytosis and recycling
|
BibTex
|
2010-10-16
|
R-GGA-517856
|
TLR2 subfamily cascade
|
BibTex
|
2010-10-16
|
R-GGA-433794
|
TLR4 cascade
|
BibTex
|
2010-10-16
|
R-GGA-451514
|
MyD88:TIRAP-dependent cascade initiated on plasma membrane
|
BibTex
|
2010-10-16
|
R-GGA-433822
|
NFkB and MAPK activation mediated by TRAF6
|
BibTex
|
2010-10-15
|
R-GGA-451478
|
ERK activation
|
BibTex
|
2010-05-23
|
R-GGA-437987
|
Toll-like receptors (TLR) cascades
|
BibTex
|
2010-05-23
|
R-GGA-434048
|
TLR3 cascade
|
BibTex
|
2010-05-23
|
R-GGA-433835
|
IKK related kinases bound to dsRNA:TLR3:TICAM1 activate IRF3
|
BibTex
|
2010-05-23
|
R-GGA-434136
|
Viral dsRNA:TLR3:TICAM1 Complex Activates TBK1
|
BibTex
|
2010-05-23
|
R-GGA-433819
|
Viral dsRNA:TLR3:TICAM1 Complex Activates IKBKE_CHICK
|
BibTex
|
2010-05-23
|
R-GGA-433871
|
TRAF6 mediated induction of proinflammatory cytokines
|
BibTex
|
2010-05-23
|
R-GGA-434131
|
NFkB activation mediated by RIP1 complexed with activated TLR3
|
BibTex
|
2010-05-23
|
R-GGA-451524
|
MAPK activation in TLR cascade
|
BibTex
|
2010-05-23
|
R-GGA-437980
|
Activated TAK1 mediates p38 MAP kinase phosphorylation
|
BibTex
|
2010-05-23
|
R-GGA-437986
|
Activated TAK1 mediates Jun kinases (JNK) phosphorylation and activation
|
BibTex
|
2010-05-23
|
R-GGA-434001
|
TAK1 activates NFkB by phosphorylation and activation of IKKs complex
|
BibTex
|
2009-12-12
|
R-HSA-500792
|
GPCR ligand binding
|
BibTex
|
2009-12-12
|
R-HSA-444209
|
Free fatty acid receptors
|
BibTex
|
2009-12-12
|
R-HSA-444473
|
Formyl peptide receptors bind formyl peptides and many other ligands
|
BibTex
|
2009-12-12
|
R-HSA-444821
|
Relaxin receptors
|
BibTex
|
2009-09-07
|
R-HSA-422356
|
Regulation of insulin secretion
|
BibTex
|
2009-08-22
|
R-GGA-433584
|
Sphingolipid metabolism
|
BibTex
|
2009-06-02
|
R-HSA-400042
|
Adrenaline,noradrenaline inhibits insulin secretion
|
BibTex
|
2009-05-29
|
R-HSA-373080
|
Class B/2 (Secretin family receptors)
|
BibTex
|
2009-05-29
|
R-HSA-420092
|
Glucagon-type ligand receptors
|
BibTex
|
2009-05-29
|
R-HSA-419812
|
Calcitonin-like ligand receptors
|
BibTex
|
2009-05-29
|
R-HSA-420499
|
Class C/3 (Metabotropic glutamate/pheromone receptors)
|
BibTex
|
2009-05-29
|
R-HSA-419771
|
Opsins
|
BibTex
|
2009-05-29
|
R-HSA-391903
|
Eicosanoid ligand-binding receptors
|
BibTex
|
2009-05-29
|
R-HSA-391906
|
Leukotriene receptors
|
BibTex
|
2009-05-29
|
R-HSA-391908
|
Prostanoid ligand receptors
|
BibTex
|
2009-05-29
|
R-HSA-417957
|
P2Y receptors
|
BibTex
|
2009-05-29
|
R-HSA-417973
|
Adenosine P1 receptors
|
BibTex
|
2009-05-29
|
R-HSA-418038
|
Nucleotide-like (purinergic) receptors
|
BibTex
|
2009-05-29
|
R-HSA-419408
|
Lysosphingolipid and LPA receptors
|
BibTex
|
2009-05-27
|
R-HSA-400253
|
Circadian Clock
|
BibTex
|
2009-05-27
|
R-HSA-1368108
|
BMAL1:CLOCK,NPAS2 activates circadian gene expression
|
BibTex
|
2009-05-27
|
R-HSA-381340
|
Transcriptional regulation of white adipocyte differentiation
|
BibTex
|
2009-05-23
|
R-GGA-421984
|
Heme synthesis
|
BibTex
|
2009-05-16
|
R-GGA-421223
|
De novo synthesis of GMP
|
BibTex
|
2009-05-16
|
R-GGA-421203
|
De novo synthesis of AMP
|
BibTex
|
2009-05-15
|
R-GGA-421178
|
Urate synthesis
|
BibTex
|
2009-04-29
|
R-GGA-419140
|
De novo synthesis of IMP
|
BibTex
|
2009-03-02
|
R-HSA-375280
|
Amine ligand-binding receptors
|
BibTex
|
2009-03-02
|
R-HSA-390666
|
Serotonin receptors
|
BibTex
|
2009-03-02
|
R-HSA-390650
|
Histamine receptors
|
BibTex
|
2009-03-02
|
R-HSA-390651
|
Dopamine receptors
|
BibTex
|
2009-03-02
|
R-HSA-390696
|
Adrenoceptors
|
BibTex
|
2009-03-02
|
R-HSA-389397
|
Orexin and neuropeptides FF and QRFP bind to their respective receptors
|
BibTex
|
2009-03-02
|
R-HSA-380095
|
Tachykinin receptors bind tachykinins
|
BibTex
|
2009-03-02
|
R-HSA-388479
|
Vasopressin-like receptors
|
BibTex
|
2009-03-02
|
R-HSA-375281
|
Hormone ligand-binding receptors
|
BibTex
|
2009-03-02
|
R-HSA-390648
|
Muscarinic acetylcholine receptors
|
BibTex
|
2008-12-02
|
R-HSA-264876
|
Insulin processing
|
BibTex
|
2008-12-02
|
R-HSA-381119
|
Unfolded Protein Response (UPR)
|
BibTex
|
2008-12-02
|
R-HSA-381033
|
ATF6 (ATF6-alpha) activates chaperones
|
BibTex
|
2008-12-02
|
R-HSA-381183
|
ATF6 (ATF6-alpha) activates chaperone genes
|
BibTex
|
2008-12-02
|
R-HSA-381070
|
IRE1alpha activates chaperones
|
BibTex
|
2008-12-02
|
R-HSA-381038
|
XBP1(S) activates chaperone genes
|
BibTex
|
2008-12-02
|
R-HSA-381426
|
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
|
BibTex
|
2008-12-02
|
R-HSA-1799339
|
SRP-dependent cotranslational protein targeting to membrane
|
BibTex
|
2008-12-02
|
R-HSA-380994
|
ATF4 activates genes in response to endoplasmic reticulum stress
|
BibTex
|
2008-12-02
|
R-HSA-381042
|
PERK regulates gene expression
|
BibTex
|
2008-11-29
|
R-HSA-209952
|
Peptide hormone biosynthesis
|
BibTex
|
2008-11-29
|
R-HSA-209822
|
Glycoprotein hormones
|
BibTex
|
2008-09-10
|
R-GGA-187630
|
Arginine metabolism
|
BibTex
|
2008-06-12
|
R-HSA-350562
|
Regulation of ornithine decarboxylase (ODC)
|
BibTex
|
2008-06-12
|
R-HSA-351202
|
Metabolism of polyamines
|
BibTex
|
2008-06-12
|
R-HSA-351200
|
Interconversion of polyamines
|
BibTex
|
2008-06-12
|
R-HSA-351143
|
Agmatine biosynthesis
|
BibTex
|
2008-05-28
|
R-HSA-211859
|
Biological oxidations
|
BibTex
|
2008-05-28
|
R-HSA-211945
|
Phase I - Functionalization of compounds
|
BibTex
|
2008-05-28
|
R-HSA-211897
|
Cytochrome P450 - arranged by substrate type
|
BibTex
|
2008-05-28
|
R-HSA-211916
|
Vitamins
|
BibTex
|
2008-05-28
|
R-HSA-211981
|
Xenobiotics
|
BibTex
|
2008-05-28
|
R-HSA-211999
|
CYP2E1 reactions
|
BibTex
|
2008-05-28
|
R-HSA-211957
|
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2
|
BibTex
|
2008-05-28
|
R-HSA-211935
|
Fatty acids
|
BibTex
|
2008-05-28
|
R-HSA-211976
|
Endogenous sterols
|
BibTex
|
2008-05-28
|
R-HSA-211994
|
Sterols are 12-hydroxylated by CYP8B1
|
BibTex
|
2008-05-28
|
R-HSA-211979
|
Eicosanoids
|
BibTex
|
2008-05-28
|
R-HSA-211958
|
Miscellaneous substrates
|
BibTex
|
2008-05-28
|
R-HSA-140180
|
COX reactions
|
BibTex
|
2008-05-28
|
R-HSA-217271
|
FMO oxidises nucleophiles
|
BibTex
|
2008-05-28
|
R-HSA-140179
|
Amine Oxidase reactions
|
BibTex
|
2008-05-28
|
R-HSA-141333
|
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB
|
BibTex
|
2008-05-28
|
R-HSA-141334
|
PAOs oxidise polyamines to amines
|
BibTex
|
2008-05-28
|
R-HSA-196791
|
Vitamin D (calciferol) metabolism
|
BibTex
|
2008-05-28
|
R-HSA-209905
|
Catecholamine biosynthesis
|
BibTex
|
2008-05-28
|
R-HSA-350864
|
Regulation of thyroid hormone activity
|
BibTex
|
2008-05-28
|
R-HSA-209968
|
Thyroxine biosynthesis
|
BibTex
|
2008-05-28
|
R-HSA-209931
|
Serotonin and melatonin biosynthesis
|
BibTex
|
2008-05-28
|
R-HSA-209776
|
Metabolism of amine-derived hormones
|
BibTex
|
2008-01-12
|
R-HSA-204174
|
Regulation of pyruvate dehydrogenase (PDH) complex
|
BibTex
|
2007-07-31
|
R-HSA-200425
|
Carnitine metabolism
|
BibTex
|
2007-07-10
|
R-HSA-196783
|
Coenzyme A biosynthesis
|
BibTex
|
2007-04-30
|
R-HSA-194068
|
Bile acid and bile salt metabolism
|
BibTex
|
2007-04-30
|
R-HSA-192105
|
Synthesis of bile acids and bile salts
|
BibTex
|
2007-04-30
|
R-HSA-193807
|
Synthesis of bile acids and bile salts via 27-hydroxycholesterol
|
BibTex
|
2007-04-30
|
R-HSA-193775
|
Synthesis of bile acids and bile salts via 24-hydroxycholesterol
|
BibTex
|
2007-04-30
|
R-HSA-193368
|
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
|
BibTex
|
2007-04-30
|
R-HSA-159418
|
Recycling of bile acids and salts
|
BibTex
|
2007-04-21
|
R-HSA-196071
|
Metabolism of steroid hormones
|
BibTex
|
2007-04-21
|
R-HSA-196108
|
Pregnenolone biosynthesis
|
BibTex
|
2007-04-21
|
R-HSA-193993
|
Mineralocorticoid biosynthesis
|
BibTex
|
2007-04-21
|
R-HSA-193144
|
Estrogen biosynthesis
|
BibTex
|
2007-04-21
|
R-HSA-193048
|
Androgen biosynthesis
|
BibTex
|
2007-04-21
|
R-HSA-194002
|
Glucocorticoid biosynthesis
|
BibTex
|
2007-02-03
|
R-HSA-8978868
|
Fatty acid metabolism
|
BibTex
|
2007-02-03
|
R-HSA-8979227
|
Triglyceride metabolism
|
BibTex
|
2007-02-03
|
R-HSA-163560
|
Triglyceride catabolism
|
BibTex
|
2007-02-03
|
R-HSA-75109
|
Triglyceride biosynthesis
|
BibTex
|
2007-01-22
|
R-HSA-191273
|
Cholesterol biosynthesis
|
BibTex
|
2006-11-03
|
R-HSA-9840310
|
Glycosphingolipid catabolism
|
BibTex
|
2006-10-31
|
R-HSA-168898
|
Toll-like Receptor Cascades
|
BibTex
|
2006-07-04
|
R-HSA-168179
|
Toll Like Receptor TLR1:TLR2 Cascade
|
BibTex
|
2006-07-04
|
R-HSA-181438
|
Toll Like Receptor 2 (TLR2) Cascade
|
BibTex
|
2006-07-04
|
R-HSA-174577
|
Activation of C3 and C5
|
BibTex
|
2006-07-04
|
R-HSA-166662
|
Lectin pathway of complement activation
|
BibTex
|
2006-07-04
|
R-HSA-173623
|
Classical antibody-mediated complement activation
|
BibTex
|
2006-07-04
|
R-HSA-166786
|
Creation of C4 and C2 activators
|
BibTex
|
2006-07-04
|
R-HSA-173736
|
Alternative complement activation
|
BibTex
|
2006-07-04
|
R-HSA-166663
|
Initial triggering of complement
|
BibTex
|
2006-07-04
|
R-HSA-166665
|
Terminal pathway of complement
|
BibTex
|
2006-07-04
|
R-HSA-166658
|
Complement cascade
|
BibTex
|
2006-07-04
|
R-HSA-168188
|
Toll Like Receptor TLR6:TLR2 Cascade
|
BibTex
|
2006-04-19
|
R-HSA-168256
|
Immune System
|
BibTex
|